POMALYST® (pomalidomide) is a prescription medicine, taken along with the medicine dexamethasone, used to treat people with multiple myeloma who have received at least 2 prior medicines to treat multiple myeloma, including a type of medicine known as a proteasome inhibitor and lenalidomide, and their disease has become worse during treatment or within 60 days of finishing the last treatment. It is not known if POMALYST is safe and if it works in people under 18 years of age.
Before you begin taking POMALYST, you must read and agree to all of the instructions in the POMALYST REMS® program.
POMALYST may cause serious side effects including:
Possible birth defects (deformed babies) or death of an unborn baby. Females who are pregnant or who plan to become pregnant must not take POMALYST.
POMALYST is similar to the medicine thalidomide (THALOMID®). We know thalidomide can cause severe life-threatening birth defects. POMALYST has not been tested in pregnant women. POMALYST has harmed unborn animals in animal testing.
Women who can become pregnant must have 2 negative pregnancy tests before starting on POMALYST.
Females must not get pregnant:
If you become pregnant while taking POMALYST, stop taking it right away and call your healthcare provider.
If you take POMALYST, you may have an increased risk for blood clots in your arteries, veins (deep vein thrombosis) or lungs (pulmonary embolism), or a heart attack or stroke. Most people who take POMALYST will also take a blood thinner medicine to help prevent blood clots.
POMALYST may cause serious birth defects or death of an unborn baby. Do not take POMALYST if you are pregnant, plan to become pregnant, or become pregnant during treatment with POMALYST.
POMALYST may cause serious side effects, including:
Your healthcare provider should do blood tests to check your liver function during your treatment with POMALYST